| Report ID | Date of report | Patient age | Patient gender |
| 54051 | Feb, 24, 2006 | 68 | Female |
List of drugs the patient takes:
| Drug | Ingredient(s) |
Vioxx | rofecoxib |
Diovan | valsartan |
| Name |
Arteriosclerosis |
Breast Microcalcification |
Bronchitis |
Carotid Artery Disease |
Chronic Obstructive Pulmonary Disease |
Coronary Artery Disease |
Coronary Artery Occlusion |
Depression |
Emphysema |
Haemoptysis |
Hypercholesterolaemia |
Hyperglycaemia |
Hypertension |
Lung Neoplasm |
Myocardial Infarction |
Oedema Peripheral |
Postoperative Infection |
Pulmonary Granuloma |
Renal Artery Stent Placement |
Upper Respiratory Tract Infection |
Results from eHealthMe : 2263 report(s)
Comparison with the patient:
| Name | Count (% of total reports) |
Arteriosclerosis | 83 (3.67%) |
Breast Microcalcification | 3 (0.13%) |
Bronchitis | 131 (5.79%) |
Carotid Artery Disease | 15 (0.66%) |
Chronic Obstructive Pulmonary Disease | 92 (4.07%) |
Coronary Artery Disease | 568 (25.10%) |
Coronary Artery Occlusion | 88 (3.89%) |
Depression | 322 (14.23%) |
Emphysema | 9 (0.40%) |
Haemoptysis | 3 (0.13%) |
Hypercholesterolaemia | 116 (5.13%) |
Hyperglycaemia | 34 (1.50%) |
Hypertension | 560 (24.75%) |
Lung Neoplasm | 20 (0.88%) |
Myocardial Infarction | 639 (28.24%) |
Oedema Peripheral | 275 (12.15%) |
Postoperative Infection | 4 (0.18%) |
Pulmonary Granuloma | 4 (0.18%) |
Renal Artery Stent Placement | 3 (0.13%) |
Upper Respiratory Tract Infection | 59 (2.61%) |
Top 3 (total: 822. Click here to see more) co-used drugs - potential interacting drugs:
| Name | Count (% of total co-drugs) |
Celebrex | 486 (2.08%) |
Lipitor | 474 (2.03%) |
Plavix | 385 (1.65%) |
Death reported: 49 (2.17% of total reports)
| Name | Count (% of total reports) |
Myocardial Infarction | 639 (28.24%) |
Coronary Artery Disease | 568 (25.10%) |
Hypertension | 560 (24.75%) |
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Recent drug risk analysis reports:
